SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12269648
Source:
http://linkedlifedata.com/resource/pubmed/id/12269648
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008059
,
umls-concept:C0035457
,
umls-concept:C0054201
,
umls-concept:C0087111
,
umls-concept:C0332162
,
umls-concept:C0441472
,
umls-concept:C0461725
,
umls-concept:C0599956
,
umls-concept:C1292430
,
umls-concept:C1704419
pubmed:issue
3
pubmed:dateCreated
2002-9-24
pubmed:abstractText
Budesonide aqueous nasal spray is a topical corticosteroid which at doses of 64 to 256 microg once daily has been found to be effective in the treatment of seasonal allergic rhinitis in adults and children.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9503580
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Aerosols
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Allergic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Budesonide
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1081-1206
pubmed:author
pubmed-author:CserhátiEndreE
,
pubmed-author:FokkensWytske JWJ
,
pubmed-author:PracaFatimaF
,
pubmed-author:SchadeAlexanderA
,
pubmed-author:SimonGyörgyG
,
pubmed-author:dos SantosJosé Manuel LopesJM
,
pubmed-author:van ZantenMarinusM
pubmed:issnType
Print
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
279-84
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12269648-Administration, Intranasal
,
pubmed-meshheading:12269648-Adolescent
,
pubmed-meshheading:12269648-Aerosols
,
pubmed-meshheading:12269648-Anti-Allergic Agents
,
pubmed-meshheading:12269648-Budesonide
,
pubmed-meshheading:12269648-Child
,
pubmed-meshheading:12269648-Double-Blind Method
,
pubmed-meshheading:12269648-Eosinophilia
,
pubmed-meshheading:12269648-Female
,
pubmed-meshheading:12269648-Humans
,
pubmed-meshheading:12269648-Kinetics
,
pubmed-meshheading:12269648-Male
,
pubmed-meshheading:12269648-Nasal Cavity
,
pubmed-meshheading:12269648-Quality of Life
,
pubmed-meshheading:12269648-Rhinitis, Allergic, Perennial
,
pubmed-meshheading:12269648-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.
pubmed:affiliation
Department of Otorhinolaryngology, Erasmus University Hospital Rotterdam, The Netherlands. fokkens@kno.fgg.eur.nl
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study